Aspen Pharmacare Holdings Limited
APNHF
$7.25
$0.8813.82%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.14% | 5.99% | 4.30% | 0.09% | -1.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.14% | 5.99% | 4.30% | 0.09% | -1.59% |
| Cost of Revenue | 6.75% | 8.61% | 10.00% | 4.18% | 1.02% |
| Gross Profit | 7.61% | 2.88% | -2.29% | -4.65% | -4.60% |
| SG&A Expenses | 7.89% | 5.23% | 2.01% | -1.31% | -2.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -7.14% | -14.85% | -27.21% | -16.28% | -10.37% |
| Total Operating Expenses | 6.71% | 7.11% | 6.99% | 2.09% | -0.26% |
| Operating Income | 8.84% | 1.78% | -5.28% | -7.23% | -6.55% |
| Income Before Tax | -2.20% | -9.87% | -17.34% | -22.41% | -25.00% |
| Income Tax Expenses | 17.34% | 5.49% | -6.25% | -15.07% | -20.64% |
| Earnings from Continuing Operations | -7.40% | -13.86% | -20.14% | -24.25% | -26.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.40% | -13.86% | -20.14% | -24.25% | -26.08% |
| EBIT | 8.84% | 1.78% | -5.28% | -7.23% | -6.55% |
| EBITDA | 9.55% | 2.85% | -3.98% | -6.04% | -5.59% |
| EPS Basic | -7.38% | -13.84% | -20.15% | -23.97% | -25.59% |
| Normalized Basic EPS | 8.35% | 1.40% | -5.53% | -9.91% | -11.65% |
| EPS Diluted | -7.38% | -13.84% | -20.15% | -23.97% | -25.59% |
| Normalized Diluted EPS | 8.35% | 1.40% | -5.53% | -9.91% | -11.65% |
| Average Basic Shares Outstanding | -0.03% | -0.02% | 0.00% | -0.29% | -0.58% |
| Average Diluted Shares Outstanding | -0.03% | -0.02% | 0.00% | -0.29% | -0.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.18% | 0.20% | 0.22% | 0.28% | 0.31% |